World demand for nutraceutical ingredients will expand 6.2 percent annually to $21.8 billion in 2013, serving a $236 billion global nutritional product industry. The best growth opportunities will emerge in soy protein nutrients; the functional food and beverage additives lutein, lycopene, omega-3 fatty acids, probiotics and phytosterols; vitamins A, E and D; the essential minerals calcium and magnesium; the herbal extracts ginkgo biloba and saw palmetto; and the non-herbal extracts glucosamine, chondroitin and coenzyme Q10. These and other trends, including market share and product segmentation, are presented in World Nutraceutical Ingredients, a new study from The Freedonia Group, Inc., a Cleveland-based industry research firm.
China and India will form the fastest expanding nutraceutical ingredients markets as strong economic growth allows them to upgrade and diversify food, beverage and drug production capabilities. By country, the United States will continue to be the largest global consumer of nutraceutical ingredients through 2013 due to the broad, increasing range of functional foods and beverages, nutritional preparations and natural medicines produced domestically. China will remain the largest worldwide producer based on its extensive fine chemicals industry and aggressive pursuit of export opportunities. Additionally, as economic growth promotes the expansion of its food, beverage and pharmaceutical industries, China will pass the United States as the leading consumer of nutraceutical ingredients after 2013.
World demand for nutrients and minerals will reach $12.6 billion in 2013, up 6.4 percent annually from 2008. Soy proteins and isoflavones, psyllium and resistant maltodextrin fibers, omega-3 fatty acids, probiotics, carotenoids, calcium and magnesium will see the fastest gains based on widely supported and accepted health benefits and expanding applications in adult nutritionals and functional foods and beverages. Global demand for nutraceutical vitamin ingredients will increase 5.9 percent annually to over $7 billion in 2013. Widespread popularity among consumers and increasing acceptance by medical professionals will boost global demand for herbal and non-herbal extracts 6.2 percent through 2013. Conflicting clinical and scientific testing results about actual health benefits will inhibit faster gains in the overall product group. Glucosamine (in combination with chondroitin) will generate the strongest growth in demand among non-herbal extracts due to alleged benefits in the treatment of moderate to severe arthritic conditions.
The Freedonia Group is a leading international business research company, founded in 1985, that publishes more than 100 industry research studies annually. This industry analysis provides an unbiased outlook and a reliable assessment of an industry and includes product segmentation and demand forecasts, industry trends, demand history, threats and opportunities, competitive strategies, market share determinations and company profiles.